| Lung Cancer |
1 |
1 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Small Cell Lung Cancer |
0 |
0.98 |
| Biologic Therapy |
0 |
0.76 |
| Cancer |
0 |
0.73 |
| Metastasis |
0 |
0.56 |
| Lung |
0 |
0.8 |
| Brachial |
0 |
0.26 |
| Grant |
0 |
0.17 |
| Immunotherapy |
0 |
0.13 |
| Tumor |
0 |
0.13 |
| Chemotherapy |
0 |
0.09 |
| Metabolism |
0 |
0.09 |
| Platinum |
0 |
0.09 |
| Radiation Therapy |
0 |
0.09 |
| Tyrosine Kinase Inhibitor |
0 |
0.07 |
| Distant Metastasis |
0 |
0.06 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.05 |
| Health Care Reform |
0 |
0.05 |
| HIV Infection |
0 |
0.05 |
| Biomarker |
0 |
0.04 |
| Canada |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Hand |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| KRAS |
0 |
0.04 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.04 |
| Outpatient Clinic |
0 |
0.04 |
| Thorax |
0 |
0.04 |
| Tyrosine Kinase |
0 |
0.04 |
| Weakness |
0 |
0.04 |